We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 6938X
GlaxoSmithKline PLC
05 May 2021
GlaxoSmithKline plc
Results of Annual General Meeting
GlaxoSmithKline plc ('GSK') held its Annual General Meeting ('AGM') at 2.30pm on Wednesday 5 May 2021.
The statement made by the Chairman at the AGM will shortly be available to view on GSK's website at www.gsk.com .
All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 22 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 30 March 2021, which is available on GSK's website at www.gsk.com .
Resolution Total votes % Total % Total votes Votes for (1)(2) votes against cast withheld (2) (3) Receive and adopt the 2020 Annual 1 Report 3,475,135,362 98.81 41,757,734 1.19 3,516,893,096 11,603,440 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Approve the Annual 2 report on remuneration 3,272,132,033 93.14 240,932,159 6.86 3,513,064,192 15,444,148 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 3 Sir Jonathan Symonds 3,499,343,831 99.52 16,763,629 0.48 3,516,107,460 12,371,547 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 4 Dame Emma Walmsley 3,507,017,955 99.68 11,159,384 0.32 3,518,177,339 10,359,075 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 5 Charles Bancroft 3,506,975,009 99.74 9,026,131 0.26 3,516,001,140 12,472,435 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 6 Vindi Banga 3,496,064,409 99.43 19,904,292 0.57 3,515,968,701 12,509,463 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 7 Dr Hal Barron 3,507,018,967 99.69 10,733,599 0.31 3,517,752,566 10,738,305 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 8 Dr Vivienne Cox 3,497,451,811 99.46 18,813,391 0.54 3,516,265,202 12,207,081 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 9 Lynn Elsenhans 3,434,728,312 97.69 81,301,678 2.31 3,516,029,990 12,440,783 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 10 Dr Laurie Glimcher 3,508,174,526 99.77 7,947,259 0.23 3,516,121,785 12,353,907 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 11 Dr Jesse Goodman 3,506,872,640 99.74 9,131,605 0.26 3,516,004,245 12,467,159 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 12 Iain Mackay 3,501,889,913 99.56 15,637,087 0.44 3,517,527,000 10,951,129 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-election of 13 Urs Rohner 3,484,061,208 99.10 31,702,634 0.90 3,515,763,842 12,752,529 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Re-appointment 14 of the auditor 3,512,936,007 99.84 5,521,996 0.16 3,518,458,003 10,024,350 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Remuneration of 15 the auditor 3,511,280,034 99.82 6,176,678 0.18 3,517,456,712 11,022,183 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Authority for the company to make donations to political organisations and incur political 16 expenditure 3,440,815,513 98.36 57,276,887 1.64 3,498,092,400 30,393,327 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Authority to allot 17 shares 3,362,807,250 95.66 152,632,653 4.34 3,515,439,903 13,038,799 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Disapplication of pre-emption rights - general 18 power (4) 3,368,593,428 95.88 144,660,127 4.12 3,513,253,555 15,222,364 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Disapplication of pre-emption rights - in connection with an acquisition or specified capital 19 investment (4) 3,291,504,396 93.68 221,978,886 6.32 3,513,483,282 14,999,454 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Authority for the company to purchase its own shares 20 (4) 3,449,168,275 98.36 57,436,714 1.64 3,506,604,989 21,875,135 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Exemption from statement of senior statutory auditor's 21 name 3,477,878,016 99.47 18,543,893 0.53 3,496,421,909 31,294,363 ------------------------ -------------- ------ --------------- ----- -------------- ----------- Authority for reduced notice of a general meeting other than 22 an AGM (4) 3,286,542,818 93.50 228,494,172 6.50 3,515,036,990 12,675,849 ------------------------ -------------- ------ --------------- ----- -------------- -----------
Notes:
(1) The "for" votes include those giving the Chairman discretion. In line with the notification issued to American Depositary Receipt (ADR) holders last year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in respect of the AGM resolutions. (2) Votes "for" and "against" are expressed as a percentage of the total votes cast. (3) A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution. (4) Indicates Special Resolutions requiring a 75% majority.
The following table provides further relevant information:
GSK's GSK's Twenty first Twentieth AGM AGM (2021) (2020) Issued share capital (excluding Treasury Shares) 5,031,444,276 5,017,091,542 --------------- -------------- Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) 70.11% 72.60% --------------- -------------- Total shareholder population 100,906 105,353 --------------- -------------- Total number of proxies lodged 6,089 6,268 --------------- -------------- % of shareholders who lodged proxies 6.03% 5.95% --------------- --------------
The above poll results will shortly be available on the company's website at www.gsk.com . In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
5 May 2021
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGDKPBBOBKDDPK
(END) Dow Jones Newswires
May 05, 2021 13:23 ET (17:23 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions